Medical economics

A progress check on hospital price transparency

For decades, U.S. hospitals have generally stonewalled patients who wanted to know ahead of time how much their care would cost. Now that's changing—but there's a vigorous debate over what hospitals are disclosing.

Oncology & Cancer

Critical oncology trial data remains hidden

Despite a commitment from the pharmaceutical industry in 2014 to improve data transparency, more than half of the clinical trials that led to the United States Food and Drug Administration approving anticancer medicines over ...

Medical economics

Patients burdened by cost of diagnostic imaging interpretations

(HealthDay)—Secondary interpretations of diagnostic imaging examinations result in small but real patient financial burdens, according to a study published online July 19 in the Journal of the American College of Radiology.

page 3 from 10